---
layout: minimal-medicine
title: Filgrastim
---

# Filgrastim
### Generic Name
Filgrastim

### Usage

Filgrastim is a granulocyte colony-stimulating factor (G-CSF).  Its primary use is to reduce the risk of infection, specifically febrile neutropenia, in patients with non-myeloid malignancies undergoing myelosuppressive chemotherapy.  This chemotherapy often causes a dangerously low white blood cell count (neutropenia), increasing the susceptibility to infections. Filgrastim helps stimulate the bone marrow to produce more neutrophils, a type of white blood cell crucial for fighting infection.

Beyond its primary use, Filgrastim also finds application in several other situations:

* **Acute myeloid leukemia (AML):** It helps reduce the duration of neutropenia and fever after chemotherapy in AML patients.
* **Bone marrow transplantation:** It speeds up neutrophil recovery after bone marrow transplantation and reduces the duration of neutropenia-related complications.
* **Mobilization of stem cells:** It helps mobilize hematopoietic progenitor cells (stem cells) from the bone marrow into the bloodstream, making them easier to collect for autologous stem cell transplantation.
* **Severe chronic neutropenia:** Filgrastim is used to manage congenital, cyclic, or idiopathic neutropenia, conditions characterized by persistently low neutrophil counts.  This helps reduce the frequency and severity of infections in these patients.


While the uses above are approved, Filgrastim is sometimes used off-label in other situations such as alcoholic hepatitis and certain types of anemia, though further research may be needed to fully establish its effectiveness in these contexts.  Always consult a healthcare provider for guidance on off-label uses.


### Dosage

Filgrastim dosage varies significantly depending on the condition being treated, the patient's age and weight, and the route of administration (subcutaneous injection or intravenous infusion).  The following information is for general guidance only and should not replace the advice of a healthcare professional.  Dosages are often expressed in micrograms (mcg), where 1 mcg equals 100,000 units.

**Adults:** Dosages range from 5 mcg/kg/day to 10 mcg/kg/day, adjusted based on the individual's response and specific condition. For instance, in chemotherapy-induced neutropenia, a typical starting dose is 5 mcg/kg/day subcutaneously, continuing until the absolute neutrophil count (ANC) reaches a certain level (often 10,000/mm³). In bone marrow transplantation, the dosage and route may differ.  Specific instructions must be followed as directed by a physician.

**Children:**  Pediatric dosages are weight-based and are determined by the physician based on the specific condition. The approach is similar to adult dosing, with adjustments made based on factors such as age, weight, and response to treatment.

**Important Note:**  The medication should typically not be administered within 24 hours before or after cytotoxic chemotherapy.

### Side Effects

Common side effects of Filgrastim can include:

* Bone pain
* Muscle aches
* Fatigue
* Headache
* Nausea
* Rash
* Fever

Less common, but more serious side effects can include:

* Allergic reactions (including anaphylaxis)
* Splenomegaly (enlarged spleen)
* Thrombocytopenia (low platelet count)
* Pulmonary events (e.g., alveolar hemorrhage)
* Capillary leak syndrome

If any concerning side effects occur, immediately consult a healthcare provider.

### How it Works

Filgrastim is a synthetic form of G-CSF, a naturally occurring protein that stimulates the growth and maturation of neutrophils in the bone marrow. By increasing the production and release of neutrophils, Filgrastim helps the body fight off infections more effectively, especially in situations where neutrophil counts are dangerously low due to disease or treatment.

### Precautions

* **Allergic Reactions:** Filgrastim is contraindicated in patients with a history of severe allergic reactions to G-CSFs.
* **Bone Marrow Suppression:**  While Filgrastim aims to increase neutrophil count, it’s crucial to monitor for signs of bone marrow suppression.
* **Sickle Cell Disease:** Patients with sickle cell disease are at increased risk of severe complications, including sickle cell crises.
* **Interactions:**  Filgrastim may interact with other medications; consult your physician about all medications you are taking.
* **Pregnancy and Breastfeeding:**  The safety of Filgrastim during pregnancy and breastfeeding is not fully established; consult your physician.
* **Other Precautions:**  Close monitoring of blood counts is essential, and your healthcare provider will guide you on the frequency of testing.


### FAQs

* **Q: How long does it take Filgrastim to work?** A:  The effect on neutrophil counts is usually seen within 1-2 days, but the full therapeutic effect may take longer, depending on the individual and their condition.

* **Q: How is Filgrastim stored?** A:  Filgrastim should be stored according to the manufacturer's instructions, usually refrigerated.

* **Q: Can I stop taking Filgrastim when I feel better?** A:  No. Stop only as directed by your physician.  Premature discontinuation can compromise treatment effectiveness.

* **Q: What should I do if I miss a dose?** A:  Contact your doctor for guidance.  Do not double the dose.


**Disclaimer:** This information is for general knowledge and does not constitute medical advice. Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The specific dosage and usage of Filgrastim will be determined by a physician based on individual needs and medical history.
